University of California, San Diego

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of California, San Diego sits in the top decile of US sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count).

775 total trials 143 currently recruiting 499 completed early-phase tilt top decile by trial count

University of California, San Diego: 775 sponsored US clinical trials, 143 recruiting.

University of California, San Diego sponsors 775 registered US clinical trials on ClinicalTrials.gov, 143 of them currently recruiting, and 499 completed. 104 of these trials are in Phase 3-4 (later-stage) and 170 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anorexia Nervosa, with 10 trials.

Top-decile sponsor footprint

University of California, San Diego ranks in the top decile of sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 65/100

499 of 553 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

775 total, page 6 of 16

COMPLETED NA

No Post Intubation Laryngeal Symptoms

NCT05383417

COMPLETED NA

Percutaneous Auricular Neuromodulation for Postoperative Analgesia

NCT05521516

COMPLETED NA

The YourMove Study: Optimizing Individualized and Adaptive mHealth Interventions Via Control Systems Engineering Methods

NCT05598996

COMPLETED Phase 1

Psilocybin-assisted Therapy for Phantom Limb Pain

NCT05224336

COMPLETED

Transcranial Doppler Using Wearable Ultrasound Patch

NCT06073145

COMPLETED NA

Improving Germline Testing in At-Risk Patients With Prostate Cancer

NCT05470036

COMPLETED NA

The Safer At School Early Alert HUB

NCT05642000

COMPLETED NA

Computational Cognitive Training To Boost Reward Responsiveness In Anhedonic Patients

NCT05383248

COMPLETED NA

Treating Pediatric NAFLD with Nutrition

NCT05499585

COMPLETED NA

Pulsed Electromagnetic Fields for Post-Amputation Pain

NCT05392803

COMPLETED NA

Individualized Neuromodulation for Anhedonic Depression

NCT05537285

COMPLETED NA

Pulsed Electromagnetic Fields for Postoperative Analgesia: A Randomized, Triple-Masked, Sham-Controlled Pilot Study

NCT05399355

COMPLETED NA

Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness

NCT05660070

TERMINATED Phase 1

Study of Docetaxel Combined with Cirmtuzumab in Metastatic Castration Resistant Prostate Cancer

NCT05156905

COMPLETED NA

PERsonalized Mood Augmentation Trial for Depressed Mood

NCT05662254

COMPLETED NA

Refining and Implementing Technology-Enhanced Family Navigation to Promote Early Access and Engagement With Mental Health Services for Youth With Autism

NCT05344378

COMPLETED NA

The JustWalk JITAI Study: A System Identification Experiment to Understand Just-in-Time States of Physical Activity

NCT05273437

COMPLETED NA

Onboarding Positives and PrEP Users to Engage Negatives (OPPEN): Peer-driven Education to Link YMSM of Color to PrEP

NCT05356910

COMPLETED NA

RISE - Reduce Sitting Time Among Breast Cancer Survivors

NCT05260723

COMPLETED Phase 4

Continuous Erector Spinae Plane Blocks to Treat Pain Following Percutaneous Nephrolithotomy

NCT05121168

COMPLETED NA

LinkUP: COVID-19 Intervention for Underserved Populations

NCT05181657

COMPLETED Early Phase 1

Examining the Therapeutic Potential of Botulinum Toxin Type A in the Treatment of Keloids

NCT05330078

COMPLETED NA

Effect of Kombucha Consumption on the Microbiome in Healthy Subjects

NCT06484504

COMPLETED NA

MyMenoPlan: Online Resource for Improving Women's Menopause Knowledge and Informed Decision-making

NCT05299983

COMPLETED NA

Pharmacist Provision of Medication Abortion

NCT04956731

COMPLETED NA

Human Sodium Balance Study

NCT04110262

COMPLETED NA

An Artificial Intelligence-Assisted Digital Health Lifestyle Intervention for Adults With Hypertension

NCT06337734

COMPLETED Phase 4

Progestin-Only Pill Use and Breastfeeding Study

NCT04965116

COMPLETED NA

Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol

NCT04912089

COMPLETED NA

Intervening on Women's Health for Rural Young Breast Cancer Survivors

NCT05414812

COMPLETED NA

LinkPositively: A Technology-Delivered Peer Navigation and Social Networking Intervention to Improve HIV Care

NCT04199052

TERMINATED Early Phase 1

Effects of Cannabis on Cognition and Endocannabinoid Levels in Bipolar Disorder Patients and Healthy Volunteers

NCT04231643

COMPLETED NA

Statewide System and Organizational Strategy for EBP Implementation

NCT05344534

COMPLETED

Ventilation and Perfusion in the Respiratory System

NCT05081895

COMPLETED Phase 2

Prospective Randomized Trial of CPAP for SDB in Patients Who Use Opioids

NCT04928157

COMPLETED Phase 2

Memantine Augmentation of Targeted Cognitive Training in Schizophrenia

NCT04857983

COMPLETED Phase 1

RCT of Modified Qing Fei Pai Du Tang (mQFPD) for COVID-19

NCT04939415

COMPLETED NA

RCT of Mushroom Based Natural Product to Enhance Immune Response to COVID-19 Vaccination

NCT04951336

COMPLETED Phase 3

ColoRectal Cancer Screening for Southern California Community Health Centers

NCT04941300

TERMINATED Phase 4

iPACK Block With Dexamethasone For Total Knee Replacement

NCT04917055

COMPLETED Phase 1

Prevention of Transmission of Hepatitis C Virus (HCV) From HCV-Viremic Organ Donor

NCT04596475

TERMINATED Phase 4

Continuous Erector Spinae Plane Blocks for Rib Fractures

NCT04558281

COMPLETED Phase 2

Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy

NCT04661514

COMPLETED NA

Mitochondrial Cocktail for Gulf War Illness

NCT02804828

COMPLETED NA

Amplification of Positivity to Enhance Social Connections in Anxiety and Depression

NCT04945239

COMPLETED Phase 1

Guselkumab (Anti-IL 23 Monoclonal Antibody) for Alcohol Associated Liver Disease

NCT04736966

COMPLETED Phase 4

Pectoralis Block vs Paravertebral Nerve Blocks for Breast Surgery

NCT04742309

COMPLETED Phase 1

Combination GRA and SGLT-2i Treatment in Type 1 Diabetes

NCT04545411

COMPLETED NA

Evaluating Body Acceptance Programs for Young Men

NCT04687228

COMPLETED NA

Ultrasound-Guided Percutaneous Peripheral Nerve Stimulation: A Department of Defense Funded Pragmatic Clinical Trial

NCT04713098

← Previous Page 6 of 16 Next →

Phase Distribution

PhaseTrial count
Phase 1 80
Phase 2 90
Phase 3 22
Phase 4 82

What is open in the University of California, San Diego pipeline

143 recruiting of 775 indexed (18% open); 499 completed (64%).

Phase mix: 104 late (III/IV) vs 170 early (I/II) (early-phase heavy).

Top condition: Anorexia Nervosa (10 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of California, San Diego: open-pipeline peers nationwide

Peers matched on 775 registered trials and 18% open enrollment, not the therapeutic-area sidebar.

University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 14%16%18%20%22% Total trials Recruiting share University of California, San DiegoDana-Farber Cancer InstituteMedical University of South CarolinaUniversity of ChicagoUniversity of UtahNeurocrine BiosciencesThomas Jefferson UniversityAbramson Cancer Center at Penn MedicineUniversity of Maryland, Baltimore
University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 775 trials (± recruiting share)

Sponsors near 18% open enrollment (± trial volume)

What to do with this University of California, San Diego page

775 registered trials is a research-attention snapshot, not an endorsement of University of California, San Diego or any single study.

  • 143 of University of California, San Diego's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Anorexia Nervosa is the condition University of California, San Diego studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anorexia Nervosa trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Diego pipeline card: 775 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.